Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00277680|
Recruitment Status : Unknown
Verified January 2006 by Oslo University Hospital.
Recruitment status was: Active, not recruiting
First Posted : January 16, 2006
Last Update Posted : July 6, 2011
|Condition or disease||Intervention/treatment||Phase|
|Uterine Fibroids||Procedure: Laparoscopic bilateral occlusion of uterine artery Procedure: Radiological embolization (UFE)||Not Applicable|
Uterine fibroid embolization (UFE)has become an alternative to hysterectomy for women with symptoms of uterine fibroids.Follow up studies of this new method have reported relief of menstrual bleeding by 85-90 % of the patients six to twelve months after treatment.Other studies have suggested laparoscopic bilateral occlusion of uterine arteries as an equal effective alternative, but to our knowledge there is no randomized studies published.
Patients recruitment : Women with symptoms of uterine fibroids referred to the clinic,who express a desire to avoid hysterectomy.
Study hypothesis: Laparoscopic occlusion of uterine vessels and UFE have equal effect on bleeding symptoms.
Gynecological examination, ultrasonography and magnetic resonance imaging (MRI) are performed preoperatively and after 1,3 and 6 months. Clinical follow up is planned after 1,3,6,12,24,36 and 60 months.A validated bleeding chard, Pictorial Blood Assessment Chart(PBAC)is filled in by the participants during the last menstruation period before treatment and before each control. A standardized questionnaire to assess the bleeding amount,pressure symptoms, pain, adverse events, other complains and patients satisfaction is also used.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Trial Comparing Laparoscopic Bilateral Occlusion of Uterine Vessels to Uterine Fibroid Embolization for the Treatment of Symptomatic Uterine Fibroids|
|Study Start Date :||December 2000|
|Study Completion Date :||April 2010|
- Reduction of menstrual bleeding six months after treatment measured by PBAC
- Patient assessment of symptom reduction including menorrhagia and bulk symptoms
- postoperative pain
- recovering time
- secondary interventions
- Reduction in fibroids and uterus size measured by ultrasonography and MRI
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00277680
|Ullevål University Hospital|
|Oslo, Norway, 0407|
|Study Director:||Olav Istre, MD,PhD||Ullevål University Hospital, Dept.of Obstetrics and Gynecology|
|Principal Investigator:||Kirsten Hald, MD||Ullevål University Hospital, Dept of Obstetrics and Gynecology|
|Study Chair:||Nils-Einar Kløw, MD,PhD||Ullevaal University Hospital|